Monsanto Company (MON) Position Maintained by Dean Investment Associates LLC

Dean Investment Associates LLC maintained its position in Monsanto Company (NYSE:MON) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 6,162 shares of the basic materials company’s stock at the close of the 2nd quarter. Dean Investment Associates LLC’s holdings in Monsanto were worth $698,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of MON. Signature Estate & Investment Advisors LLC raised its stake in Monsanto by 6.6% in the 1st quarter. Signature Estate & Investment Advisors LLC now owns 124,702 shares of the basic materials company’s stock worth $14,116,000 after purchasing an additional 7,680 shares in the last quarter. Capital One National Association raised its stake in Monsanto by 1.9% in the 1st quarter. Capital One National Association now owns 6,224 shares of the basic materials company’s stock worth $704,000 after purchasing an additional 114 shares in the last quarter. IndexIQ Advisors LLC raised its stake in Monsanto by 27.0% in the 1st quarter. IndexIQ Advisors LLC now owns 87,796 shares of the basic materials company’s stock worth $9,939,000 after purchasing an additional 18,649 shares in the last quarter. American Century Companies Inc. raised its stake in Monsanto by 7.5% in the 1st quarter. American Century Companies Inc. now owns 1,547,446 shares of the basic materials company’s stock worth $175,171,000 after purchasing an additional 108,293 shares in the last quarter. Finally, Meridian Management Co. raised its stake in Monsanto by 0.9% in the 1st quarter. Meridian Management Co. now owns 25,827 shares of the basic materials company’s stock worth $2,924,000 after purchasing an additional 234 shares in the last quarter. Institutional investors own 74.78% of the company’s stock.

Shares of Monsanto Company (NYSE:MON) opened at 119.41 on Wednesday. The company has a market capitalization of $52.46 billion, a price-to-earnings ratio of 25.79 and a beta of 1.07. The company’s 50 day moving average is $117.37 and its 200 day moving average is $116.53. Monsanto Company has a one year low of $97.35 and a one year high of $119.60.

Monsanto (NYSE:MON) last announced its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. The business had revenue of $4.23 billion for the quarter, compared to the consensus estimate of $4.18 billion. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. Monsanto’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period last year, the firm posted $2.17 earnings per share. Equities research analysts predict that Monsanto Company will post $4.89 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 1.81%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s dividend payout ratio is currently 46.75%.

TRADEMARK VIOLATION WARNING: This piece of content was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/09/20/monsanto-company-mon-position-maintained-by-dean-investment-associates-llc.html.

In related news, EVP Robert T. Fraley sold 52,410 shares of the firm’s stock in a transaction that occurred on Monday, July 10th. The shares were sold at an average price of $117.95, for a total value of $6,181,759.50. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Steven Mizell sold 11,300 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the completion of the sale, the executive vice president now directly owns 55,011 shares in the company, valued at $6,522,654.27. The disclosure for this sale can be found here. Company insiders own 0.79% of the company’s stock.

MON has been the subject of several analyst reports. Zacks Investment Research upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $131.00 price objective for the company in a research note on Monday, September 4th. BMO Capital Markets reiterated a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a research note on Friday, September 1st. BidaskClub cut shares of Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Vetr upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price objective for the company in a research note on Wednesday, July 12th. Finally, Susquehanna Bancshares Inc reiterated a “neutral” rating and issued a $128.00 price objective (up previously from $125.00) on shares of Monsanto in a research note on Tuesday, June 27th. Ten analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $124.09.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply